<Disease><Name>CARNOSINURIA, CARNOSINEMIA</Name><Synonym>CARNOSINASE DEFICIENCY</Synonym><OMIM><Number>212200</Number><URL>http://omim.org/entry/212200</URL></OMIM><Orphanet><Number>1361</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=1361</URL></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number>3.4.13.20</Number><URL>http://enzyme.expasy.org/EC/3.4.13.20</URL></ExPASy><Gene>18q21.3Detail information to gene locus by the National Center for Biotechnology Information NCBI:

Carnosinemia (carnosinase)
</Gene><ICD>E70.8</ICD><Summary>rare (~30 cases) ;autosomal recessive</Summary><Symptoms><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2088</id><symptom>Amino acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4041</id><symptom>seizures, myoclonic</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1596</id><name>Anserine</name><specimen>urine</specimen><value>increased</value><min>3.30</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1602</id><name>Carnosine</name><specimen>urine</specimen><value>increased</value><min>1.40</min><max>12.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>177</id><name>Anserine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>not detectable</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>2024</id><name>Anserine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>176</id><name>Anserine</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>819</id><name>Carnosinase</name><specimen>serum</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>2026</id><name>Carnosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>178</id><name>Carnosine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>19.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>179</id><name>Carnosine</name><specimen>urine</specimen><value>increased</value><min>97.00</min><max>665.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>817</id><name>Carnosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>20.00</max><unit>&#181;mol/g creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>818</id><name>Carnosine</name><specimen>serum</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>child</age><method /><comment /></metabolite><metabolite><id>814</id><name>Homocarnosine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>4.00</min><max>8.70</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7112</id><title>Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency</title><author>Peters V,</author><journal>J Inherit Metab Dis</journal><year>2018</year><book /><volume>41</volume><number>1</number><pages>39-47</pages><co_aut>Zschocke J, Schmitt CP</co_aut></literature><literature><id>3707</id><title>Does low serum carnosinase activity favor high-intensity exercise capacity?</title><author>Baguet A,</author><journal>J Appl Physiol</journal><year>2014</year><book /><volume>116</volume><number>5</number><pages>553-559</pages><co_aut>et al.</co_aut></literature><literature><id>3706</id><title>Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans</title><author>Everaert I,</author><journal>Am J Physiol Renal Physiol</journal><year>2012</year><book /><volume>302</volume><number>12</number><pages>F13537-154</pages><co_aut>et al.</co_aut></literature><literature><id>3708</id><title>A novel, quantitative assay for homocarnosine in cerebrospinal fluid using stable-isotope dilution liquid chromatography-tandem</title><author>Jansen EE,</author><journal>J Chromatogr B Analyt Technol Biomed Life Sci</journal><year>2006</year><book /><volume>830</volume><number>2</number><pages>196-200</pages><co_aut>et al.</co_aut></literature><literature><id>2965</id><title>[Carnosinemia]</title><author>Matsumura R</author><journal>Ryoikibetsu Shokogun Shirizu</journal><year>2000</year><book /><volume>29</volume><number>0</number><pages>397</pages><co_aut /></literature><literature><id>2966</id><title>[Serum carnosinase deficiency and homocarnosinosis]</title><author>Hamajima N</author><journal>Ryoikibetsu Shokogun Shirizu</journal><year>1998</year><book /><volume>18</volume><number>1</number><pages>252-254</pages><co_aut>Wada Y</co_aut></literature><literature><id>844</id><title>Disorders of small peptides</title><author>Jaeken J</author><journal>in Fernandes J, Saudubray JM, van den Berghe (eds): Inborn metabolic diseases, diagnosis and treatment; Berlin, Springer Verlag</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>201-203</pages><co_aut /></literature><literature><id>65</id><title>Disorders of beta and gamma-amino acids  in free and peptide-linked forms</title><author>Scriver CR</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1349-1368</pages><co_aut>Gibson KM</co_aut></literature><literature><id>1721</id><title>Inborn errors of carnosine and homocarnosine metabolism</title><author>Gjessing LR</author><journal>J Neural Transm Suppl</journal><year>1990</year><book /><volume>29</volume><number>0</number><pages>91-106</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>